The seventh Nordic Life Science Days united 1240 delegates from a record number of organizations across the global life science industry, to focus on improving healthcare technologies and delivery in the Nordics.
This year saw an extended first day with a number of satellite events, including educational sessions on clinical development, funding for SMEs, and advancing ATMPs into the clinic. There was also a series of pitches to showcase the best of Swedish and Danish life science from Medicon Valley, as well as the inaugural Nordic Life Science Awards.
Day 2 kicked off with the Opening Plenary session, which was delivered by Niklas Johansson, State Secretary to the Minister for Foreign Trade. He discussed the Swedish Government’s commitment to innovation and the need for the industry to work together. Co-creation and collaboration continued to be common threads during many of the day’s panel discussions and seminars. Financing and investment were also strong themes – from feeding innovation, which always needs funding, to health economics and preparing for an IPO.
The collaboration theme continued during day 3’s panel sessions and seminars, which focused on metabolic diseases, oncology and individualized medicine. Discussions moved on to address how organizations across the Nordic ecosystem can work together to leverage local strongholds, and take a globally leading position for addressing future healthcare challenges.
The event also featured 46 company presentations with updates from organizations of all sizes, and 2 750 partnering meetings for delegates throughout the event.
Olivier Duchamp, Managing Director, NLSDays wrapped up the show:
NLSDays in brief
Registered delegates: 1 240
Meetings scheduled: 2 750
Malmö again next year
NLSDays will return to MalmöMässan next year from 8-10 September 2020.
Managing Director, NLSDays
+33 (0) 467 912 113
+46 (0) 702 381 149
NLSDays, which is organized by SwedenBIO, has grown rapidly since its launch in 2012 and has developed into the largest Nordic partnering conference for the international life science industry.
SwedenBIO, the trade association for the Swedish life science sector has more than 260 members operating across all sub-sectors from pharmaceutical, biotechnology, medical technology to diagnostics. SwedenBIO serves to the benefit the entire life science industry in Sweden and is a member-driven, private, non-profit organization. The main objective is to contribute to improving the conditions for the life science industry for the benefit of industry growth and business development. Sweden’s life science industry accounts for 20% of Sweden’s net exports.